Observational study on the efficacy of rituximab, zanubrutinib, and venetoclax combination therapy for diffuse large B-cell lymphoma

Su Yutai, Luo Xueping, Fu Shan, Li Yi, Li Jingwen, Zheng Weiyan, Ma Ping, Wang Haijun

PDF(953 KB)
Modern Medicine Journal of China ›› 2025, Vol. 27 ›› Issue (3) : 8-13. DOI: 10.3969/j.issn.1672-9463.2025.03.002

Observational study on the efficacy of rituximab, zanubrutinib, and venetoclax combination therapy for diffuse large B-cell lymphoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(3): 8-13 https://doi.org/10.3969/j.issn.1672-9463.2025.03.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(953 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉